Medical devices, healthcare technology and the business of care
510(k) clearance · K253261

Apollo Quattro (APQ-10M)

Weero Co., Ltd. · Decision date Mar 13, 2026

FDA DECISIONK253261

What did the FDA decide?

FDA records K253261 as a 510(k) premarket notification, with a decision dated Mar 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Mar 13, 2026

FDA source record

Regulatory record facts

Identifier
K253261
Regulatory pathway
510(k) premarket notification
Product code
PBX
Decision code
SESE
Decision date
Mar 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Massager, Vacuum, Radio Frequency Induced Heat.

Product code
PBX
FDA device class
2

FDA decision timeline

  1. K253261 received

    Application receipt date recorded by FDA.

  2. K253261 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PBX

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Dongdixin Technology Co., Ltd.510(k) clearanceOct 13, 2026FDA
Bh Group Us, LLC510(k) clearanceSep 22, 2026FDA
Capenergy Medical S.L.510(k) clearanceJul 10, 2026FDA
SPECCHIOK260647
El.En S.P.A.510(k) clearanceApr 2, 2026FDA
S&M Medical Co., Ltd.510(k) clearanceMar 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Weero Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Suwon

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records